These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 20949125

  • 1. SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells.
    Poat B, Hazari S, Chandra PK, Gunduz F, Balart LA, Alvarez X, Dash S.
    PLoS One; 2010 Sep 30; 5(9):. PubMed ID: 20949125
    [Abstract] [Full Text] [Related]

  • 2. Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication.
    Poat B, Hazari S, Chandra PK, Gunduz F, Alvarez X, Balart LA, Garry RF, Dash S.
    Virol J; 2010 Oct 12; 7():265. PubMed ID: 20939906
    [Abstract] [Full Text] [Related]

  • 3. Modification of the Stat1 SH2 domain broadly improves interferon efficacy in proportion to p300/CREB-binding protein coactivator recruitment.
    Zhang Y, Takami K, Lo MS, Huang G, Yu Q, Roswit WT, Holtzman MJ.
    J Biol Chem; 2005 Oct 07; 280(40):34306-15. PubMed ID: 16107341
    [Abstract] [Full Text] [Related]

  • 4. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR, Lazaro CA, Fausto N, Polyak SJ.
    Virol J; 2005 Dec 02; 2():89. PubMed ID: 16324217
    [Abstract] [Full Text] [Related]

  • 5. Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon.
    Hazari S, Taylor L, Haque S, Garry RF, Florman S, Luftig R, Regenstein F, Dash S.
    Virol J; 2007 Sep 18; 4():89. PubMed ID: 17877826
    [Abstract] [Full Text] [Related]

  • 6. STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α.
    Yamauchi S, Takeuchi K, Chihara K, Honjoh C, Kato Y, Yoshiki H, Hotta H, Sada K.
    Sci Rep; 2016 Dec 08; 6():38336. PubMed ID: 27929099
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of HCV NS5A on STAT1 phosphorylation and nuclear translocation induced by IFN alpha-2b].
    Cao J, Zhou Y, Gong GZ.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Dec 08; 14(12):894-7. PubMed ID: 17196131
    [Abstract] [Full Text] [Related]

  • 12. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
    Radaeva S, Jaruga B, Kim WH, Heller T, Liang TJ, Gao B.
    Biochem J; 2004 Apr 01; 379(Pt 1):199-208. PubMed ID: 14690454
    [Abstract] [Full Text] [Related]

  • 13. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
    Wang W, Yin Y, Xu L, Su J, Huang F, Wang Y, Boor PPC, Chen K, Wang W, Cao W, Zhou X, Liu P, van der Laan LJW, Kwekkeboom J, Peppelenbosch MP, Pan Q.
    Sci Signal; 2017 Apr 25; 10(476):. PubMed ID: 28442624
    [Abstract] [Full Text] [Related]

  • 14. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B, Chen S, Guan Y, Chen L.
    PLoS One; 2015 Apr 25; 10(7):e0133800. PubMed ID: 26193702
    [Abstract] [Full Text] [Related]

  • 15. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
    Jia Y, Wei L, Jiang D, Wang J, Cong X, Fei R.
    J Gastroenterol Hepatol; 2007 Aug 25; 22(8):1278-85. PubMed ID: 17565587
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis C virus non-structural 5A abrogates signal transducer and activator of transcription-1 nuclear translocation induced by IFN-alpha through dephosphorylation.
    Gong GZ, Cao J, Jiang YF, Zhou Y, Liu B.
    World J Gastroenterol; 2007 Aug 14; 13(30):4080-4. PubMed ID: 17696225
    [Abstract] [Full Text] [Related]

  • 17. PCBP2 enhances the antiviral activity of IFN-α against HCV by stabilizing the mRNA of STAT1 and STAT2.
    Xin Z, Han W, Zhao Z, Xia Q, Yin B, Yuan J, Peng X.
    PLoS One; 2011 Aug 14; 6(10):e25419. PubMed ID: 22022391
    [Abstract] [Full Text] [Related]

  • 18. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.
    Larrea E, Aldabe R, Molano E, Fernandez-Rodriguez CM, Ametzazurra A, Civeira MP, Prieto J.
    Gut; 2006 Aug 14; 55(8):1188-96. PubMed ID: 16120756
    [Abstract] [Full Text] [Related]

  • 19. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
    Lanford RE, Guerra B, Lee H, Averett DR, Pfeiffer B, Chavez D, Notvall L, Bigger C.
    J Virol; 2003 Jan 14; 77(2):1092-104. PubMed ID: 12502825
    [Abstract] [Full Text] [Related]

  • 20. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
    Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, Crawford JM, Nelson DR, She JX, Liu C.
    Hepatology; 2003 May 14; 37(5):1180-8. PubMed ID: 12717400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.